$31.91
1.72% day before yesterday
Nasdaq, Nov 01, 09:00 pm CET
ISIN
US8753722037
Symbol
TNDM

Tandem Diabetes Care, Inc. Stock price

$31.91
-9.16 22.30% 1M
-4.29 11.85% 6M
+2.33 7.88% YTD
+14.16 79.77% 1Y
-104.81 76.66% 3Y
-30.44 48.82% 5Y
-131.39 80.46% 10Y
Nasdaq, Closing price Fri, Nov 01 2024
+0.54 1.72%
ISIN
US8753722037
Symbol
TNDM
Sector

Key metrics

Market capitalization $2.09b
Enterprise Value $2.11b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.66
P/S ratio (TTM) P/S ratio 2.62
P/B ratio (TTM) P/B ratio 8.93
Revenue growth (TTM) Revenue growth 0.72%
Revenue (TTM) Revenue $796.00m
EBIT (operating result TTM) EBIT $-139.06m
Free Cash Flow (TTM) Free Cash Flow $-41.95m
Cash position $452.42m
EPS (TTM) EPS $-2.09
P/E forward negative
P/S forward 2.34
EV/Sales forward 2.37
Short interest 21.53%
Show more

Is Tandem Diabetes Care, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.

Tandem Diabetes Care, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Tandem Diabetes Care, Inc. forecast:

15x Buy
68%
6x Hold
27%
1x Sell
5%

Analyst Opinions

22 Analysts have issued a Tandem Diabetes Care, Inc. forecast:

Buy
68%
Hold
27%
Sell
5%

Financial data from Tandem Diabetes Care, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
796 796
1% 1%
100%
- Direct Costs 405 405
5% 5%
51%
391 391
3% 3%
49%
- Selling and Administrative Expenses 333 333
6% 6%
42%
- Research and Development Expense 180 180
4% 4%
23%
-123 -123
11% 11%
-15%
- Depreciation and Amortization 16 16
9% 9%
2%
EBIT (Operating Income) EBIT -139 -139
9% 9%
-17%
Net Profit -136 -136
39% 39%
-17%

In millions USD.

Don't miss a Thing! We will send you all news about Tandem Diabetes Care, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Tandem Diabetes Care, Inc. Stock News

Neutral
Business Wire
4 days ago
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will host meetings and present a company update at the following investor conferences: UBS Global Healthcare Conference on Thursday, November 14, 2024 at 11:45am Eastern Time (8:45am Pacific Time), Stifel 2024 Healthcare Conference on...
Neutral
Business Wire
about one month ago
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2024 results after the financial markets close on Wednesday, November 6, 2024. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its third qu...
Neutral
The Motley Fool
about one month ago
Flat revenue growth might be in store for the company in a very crucial market.
More Tandem Diabetes Care, Inc. News

Company Profile

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.

Head office United States
CEO John Sheridan
Employees 2,400
Founded 2006
Website www.tandemdiabetes.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today